Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical Trials. - Ingram, John R.; Fujita, Hideki; Gottlieb, Alice B.; Lev-Tov, Hadar; Prens, Errol; Sayed, Christopher J.; Shi, Vivian Y.; Szepietowski, Jacek C.; Takahashi, Kenzo; Frew, John W.; Lambert, Jérémy; Davis, Leah; et al. (Pain & Therapy, 2025)